Afra Anjum, Leo Nicolai, Rainer Kaiser/LinkedIn
Sep 14, 2025, 23:06
Platelet Heterogeneity In Disease: The Many and The Diverse?
Leo Nicolai, Head of Junior Research Group and Clinician Scientist at LMU Medical Center Munich, shared on LinkedIn:
”Happy to see our invited review in Blood written by Rainer Kaiser, Afra Anjum and myself now online, hope you enjoy the read
Complicated and controversial topic, happy to discuss and lets see what the next years of science show!”
Read the full review in Blood.
Article: Platelet heterogeneity in disease: the many and the diverse?
Authors: Rainer Kaiser, Afra Anjum, Leo Nicolai
Stay updated on all scientific advances in the field of platelet disorders with Hemostasis Today.
-
Aug 29, 2026, 17:05What If Factor XI inhibition Could Reshape the Future of Anticoagulation – ISTH
-
Aug 29, 2026, 16:44Nipocalimab for Warm Autoimmune Hemolytic Anemia: What the FDA Approval Means
-
Aug 29, 2026, 16:17The Future of Bleeding Disorder Research is Getting Bigger – Global Hemophilia Report
-
Aug 29, 2026, 16:03Marco De Giovanni: The Platelet – Serotonin Link Behind Severe COVID-19
-
Aug 29, 2026, 16:01FDA Approves Imaavy for wAIHA – Thalassaemia International Federation
-
Aug 29, 2026, 16:00Dianne E. van der Wal: Advancing Platelet Research at ISTH 2026 in Paris
-
Aug 29, 2026, 15:55Cory Dugan: Iron Deficiency and Anemia Across the Female Life
-
Aug 29, 2026, 15:53Melina Rodriguez: FDA Approves Imaavy as First Treatment for Warm AIHA
-
Aug 29, 2026, 15:50Karen T․: Seeking a Patient Liaison to Support the Bleeding Disorders Community